Role of PrPC Expression in Tau Protein Levels and Phosphorylation in Alzheimer’s Disease Evolution

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Molecular Neurobiology

• Publication date

  2014-06-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12035-014-8793-7PMID 24965601
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amyloid-beta / Fyn – Induced Synaptic , Network , and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer ’ s Disease

  2015cited by this paper
• Glycogen Synthase Kinase 3 Beta (GSK3β) at the Tip of Neuronal Development and Regeneration

  2014cited by this paper
• Amyloid Deposition Is Linked to Aberrant Entorhinal Activity among Cognitively Normal Older Adults

  2014cited by this paper
• SIRPα polymorphisms, but not the prion protein, control phagocytosis of apoptotic cells

  2013cited by this paper
• Prion Protein Is Decreased in Alzheimer's Brain and Inversely Correlates with BACE1 Activity, Amyloid-β Levels and Braak Stage

  2013cited by this paper
• Gene Expression Resulting from PrPC Ablation and PrPC Overexpression in Murine and Cellular Models

  2013cited by this paper
• Cellular prion protein modulates β-amyloid deposition in aged APP/PS1 transgenic mice.

  2013cited by this paper
• Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease

  2013cited by this paper
• Impact of the Cellular Prion Protein on Amyloid-β and 3PO-Tau Processing

  2013cited by this paper
• Oxidative Stress and the Pathogenesis of Alzheimer's Disease

  2013cited by this paper
• Tau pathology and neurodegeneration.

  2013cited by this paper
• Alzheimer's amyloid-β oligomers rescue cellular prion protein induced tau reduction via the Fyn pathway.

  2013cited by this paper
• PrP mRNA and protein expression in brain and PrPc in CSF in Creutzfeldt-Jakob disease MM1 and VV2

  2013cited by this paper
• Alzheimer Amyloid-β Oligomer Bound to Post-Synaptic Prion Protein Activates Fyn to Impair Neurons

  2012cited by this paper
• The Complex PrPc-Fyn Couples Human Oligomeric Aβ with Pathological Tau Changes in Alzheimer's Disease

  2012cited by this paper
• Propagation of tau pathology in a model of early Alzheimer's disease.

  2012cited by this paper
• Regulation of amyloid-β production by the prion protein

  2012cited by this paper
• Role of the Cellular Prion Protein in Oligodendrocyte Precursor Cell Proliferation and Differentiation in the Developing and Adult Mouse CNS

  2012cited by this paper
• Serum tau protein as a marker for the diagnosis of Creutzfeldt-Jakob disease

  2011cited by this paper
• The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

  2011cited by this paper
• Altered Intracellular Distribution of PrPC and Impairment of Proteasome Activity in Tau Overexpressing Cortical Neurons

  2011cited by this paper
• Neuroprotective role of PrPC against kainate-induced epileptic seizures and cell death depends on the modulation of JNK3 activation by GluR6/7–PSD-95 binding

  2011cited by this paper
• Developmental influence of the cellular prion protein on the gene expression profile in mouse hippocampus.

  2011cited by this paper
• Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease

  2011cited by this paper
• Accumulation of cellular prion protein within dystrophic neurites of amyloid plaques in the Alzheimer's disease brain

  2011cited by this paper
• A Novel PRNP Y218N Mutation in Gerstmann-Sträussler-Scheinker Disease With Neurofibrillary Degeneration

  2010cited by this paper
• Aβ Oligomers Cause Localized Ca2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines

  2010cited by this paper
• Changes of tau profiles in brains of the hamsters infected with scrapie strains 263 K or 139 A possibly associated with the alteration of phosphate kinases

  2010cited by this paper
• Memory Impairment in Transgenic Alzheimer Mice Requires Cellular Prion Protein

  2010cited by this paper
• Intracellular and Extracellular Tau

  2010cited by this paper
• Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models.

  2010cited by this paper
• Animal models reveal role for tau phosphorylation in human disease.

  2010cited by this paper
• Prions

  2010cited by this paper
• New insights into cellular prion protein (PrPc) functions: the "ying and yang" of a relevant protein.

  2009cited by this paper
• Prions: protein aggregation and infectious diseases.

  2009cited by this paper
• Context dependent neuroprotective properties of prion protein (PrP)

  2009influential reference
• Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-β Oligomers

  2009cited by this paper
• Faculty Opinions recommendation of Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.

  2009cited by this paper
• Regulation of GABAA and Glutamate Receptor Expression, Synaptic Facilitation and Long-Term Potentiation in the Hippocampus of Prion Mutant Mice

  2009cited by this paper
• Ying and Yang

  2009cited by this paper
• The cellular prion protein and its role in Alzheimer disease

  2009cited by this paper
• Prion protein region 23–32 interacts with tubulin and inhibits microtubule assembly

  2009cited by this paper
• Cdk5 acts as a mediator of neuronal cell cycle re-entry triggered by amyloid-β and prion peptides

  2009cited by this paper
• Pin1 affects Tau phosphorylation in response to Abeta oligomers.

  2009cited by this paper
• Tau isoform regulation is region‐ and cell‐specific in mouse brain

  2008cited by this paper
• Human tau protein forms complex with PrP and some GSS- and fCJD-related PrP mutants possess stronger binding activities with tau in vitro

  2008cited by this paper
• Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers

  2008cited by this paper
• Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers.

  2008cited by this paper
• Membrane‐bound β‐amyloid oligomers are recruited into lipid rafts by a fyn‐dependent mechanism

  2008cited by this paper
• The GSK3 hypothesis of Alzheimer's disease

  2008cited by this paper
• The cellular prion protein (PrP(C)): its physiological function and role in disease.

  2007cited by this paper
• Cellular prion protein regulates β-secretase cleavage of the Alzheimer's amyloid precursor protein

  2007cited by this paper
• Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model

  2007cited by this paper
• Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress.

  2006cited by this paper
• Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease.

  2006cited by this paper
• The Roles of Cyclin-dependent Kinase 5 and Glycogen Synthase Kinase 3 in Tau Hyperphosphorylation*

  2006cited by this paper
• Neuronal Pentraxin 1 Contributes to the Neuronal Damage Evoked by Amyloid-β and Is Overexpressed in Dystrophic Neurites in Alzheimer's Brain

  2006cited by this paper
• Prion protein (PrPc) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis.

  2006cited by this paper
• Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates.

  2005cited by this paper
• Expression of Cellular Prion Protein in the Frontal and Occipital Lobe in Alzheimer's Disease, Diffuse Lewy Body Disease, and in Normal Brain: An Immunohistochemical Study

  2005cited by this paper
• Cell-Cycle Reentry and Cell Death in Transgenic Mice Expressing Nonmutant Human Tau Isoforms

  2005cited by this paper
• Prion protein (PrP c ) promotes -amyloid plaque formation

  2005cited by this paper
• Prion protein (PrPc) promotes beta-amyloid plaque formation.

  2005cited by this paper
• PrP(106–126) activates neuronal intracellular kinases and Egr1 synthesis through activation of NADPH‐oxidase independently of PrPc

  2005cited by this paper
• Expression of PrP(C) in the rat brain and characterization of a subset of cortical neurons.

  2005cited by this paper
• Phosphorylation of Tau by Fyn: Implications for Alzheimer's Disease

  2004cited by this paper
• Prion protein is a component of the multimolecular signaling complex involved in T cell activation

  2004cited by this paper
• Cdk5 deregulation in the pathogenesis of Alzheimer's disease.

  2004cited by this paper
• Role of tau protein in both physiological and pathological conditions.

  2004cited by this paper
• Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3.

  2003cited by this paper
• Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.

  2003cited by this paper
• Process Outgrowth of Oligodendrocytes Is Promoted by Interaction of Fyn Kinase with the Cytoskeletal Protein Tau

  2002cited by this paper
• Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

  2002cited by this paper
• The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodies

  2002cited by this paper
• Lithium inhibits amyloid secretion in COS7 cells transfected with amyloid precursor protein C100.

  2002cited by this paper
• Selective expression of prion protein in peripheral tissues of the adult mouse.

  2002cited by this paper
• Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets.

  2002cited by this paper
• Co-expression of multiple transgenes in mouse CNS: a comparison of strategies.

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicity.

  2000cited by this paper
• Prion protein expression in senile plaques in Alzheimer's disease

  2000cited by this paper
• Signal transduction through prion protein.

  2000cited by this paper
• Embryonic stem cells and transgenic mice ubiquitously expressing a tau-tagged green fluorescent protein.

  2000cited by this paper
• Tau aggregation into fibrillar polymers: taupathies

  2000cited by this paper
• Fresh and globular amyloid β protein (1–42) induces rapid cellular degeneration: evidence for AβP channel‐mediated cellular toxicity

  2000cited by this paper
• Evolution of Alzheimer's disease related cortical lesions.

  1998cited by this paper
• Nobel Lecture: Prions

  1998cited by this paper
• Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

  1998cited by this paper
• Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

  1997cited by this paper
• Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity.

  1997cited by this paper
• Evolution of the neuropathology of Alzheimer's disease

  1996cited by this paper
• Site-specific regulation of Alzheimer-like tau phosphorylation in living neurons.

  1996cited by this paper
• Prion protein (PrP) with amino‐proximal deletions restoring susceptibility of PrP knockout mice to scrapie.

  1996cited by this paper
• Developmental expression of the prion protein gene in glial cells.

  1995cited by this paper
• The protein tyrosine kinase, fyn, in Alzheimer's disease pathology

  1993cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper
• Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein

  1992cited by this paper
• Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain Sections

  1991cited by this paper
• Novel proteinaceous infectious particles cause scrapie.

  1982cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Cellular Prion Protein and Amyloid-β Oligomers in Alzheimer’s Disease—Are There Connections?

  2025cites this paper
• Exploring the Biological Connection Between Tau and PrPC in Neuronal Cells: GSK3β as a Possible Key Player

  2025influential citation
• Tau oligomers impair memory and synaptic plasticity through the cellular prion protein

  2025cites this paper
• Sex- and region-specific cortical and hippocampal whole genome transcriptome profiles from control and APP/PS1 Alzheimer’s disease mice

  2024cites this paper
• Roles of Lysine Methylation in Glucose and Lipid Metabolism: Functions, Regulatory Mechanisms, and Therapeutic Implications

  2024cites this paper
• Fyn Kinase in Alzheimer’s Disease: Unraveling Molecular Mechanisms and Therapeutic Implications

  2024cites this paper
• miR-519a-3p, found to regulate cellular prion protein during Alzheimer's disease pathogenesis, as a biomarker of asymptomatic stages.

  2024cites this paper
• PrP meets alpha‐synuclein: Molecular mechanisms and implications for disease

  2023cites this paper
• Inducing prion protein shedding as a neuroprotective and regenerative approach in pathological conditions of the brain: from theory to facts

  2023cites this paper
• The multiple functions of PrPC in physiological, cancer, and neurodegenerative contexts

  2022cites this paper
• Cellular prion protein offers neuroprotection in astrocytes submitted to amyloid β oligomer toxicity

  2022cites this paper
• Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.

  2022cites this paper
• Behavioral deficits, learning impairment, and enhanced hippocampal excitability in co-isogenic PrnpZH3/ZH3 mice

  2021cites this paper
• Neurotoxicity of oligomers of phosphorylated Tau protein carrying tauopathy-associated mutation is inhibited by prion protein.

  2021cites this paper
• Cellular Prion Protein and Amyloid – β Oligomers in Alzheimer's Disease – There Are Connections?

  2021cites this paper
• Tau Exon 10 Inclusion by PrPC through Downregulating GSK3β Activity

  2021influential citation
• Tau Protein as a New Regulator of Cellular Prion Protein Transcription

  2020cites this paper
• The Quest for Cellular Prion Protein Functions in the Aged and Neurodegenerating Brain

  2020cites this paper
• LRP::FLAG Reduces Phosphorylated Tau Levels in Alzheimer’s Disease Cell Culture Models

  2020cites this paper
• Rutaecarpine Ameliorated High Sucrose-Induced Alzheimer's Disease Like Pathological and Cognitive Impairments in Mice

  2020cites this paper
• Noves funcions de PrP(c) en neurotransmissió, neuroprotecció i neurodegeneració

  2019cites this paper
• Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein

  2019cites this paper
• Cellular Prion Protein as a Receptor of Toxic Amyloid-β42 Oligomers Is Important for Alzheimer’s Disease

  2019cites this paper
• Neuronally derived extracellular vesicles: an emerging tool for understanding Alzheimer’s disease

  2019cites this paper
• Role of cellular prion protein in interneuronal amyloid transmission.

  2018cites this paper
• Synaptotoxic Signaling by Amyloid Beta Oligomers in Alzheimer's Disease Through Prion Protein and mGluR5.

  2018cites this paper
• Physiological Functions of the Cellular Prion Protein

  2017cites this paper
• Investigating therapeutic strategies in a preclinical model for Alzheimer's disease

  2017cites this paper
• Impact of Phosphorylation and Pseudophosphorylation on the Early Stages of Aggregation of the Microtubule-Associated Protein Tau.

  2017cites this paper
• Cdk5 at crossroads of protein oligomerization in neurodegenerative diseases: facts and hypotheses

  2016cites this paper
• Florbetapir positron emission tomography and cerebrospinal fluid biomarkers

  2015cites this paper
• Glutamate receptors function as scaffolds for the regulation of β-amyloid and cellular prion protein signaling complexes

  2015cites this paper
• Papel regulador de la proteína priónica celular en la enfermedad de Alzheimer y uso de gamma-péptidos como potenciales agentes terapéuticos

  2015cites this paper
• The Binding Receptors of Aβ: an Alternative Therapeutic Target for Alzheimer’s Disease

  2014cites this paper
• Prion Protein Signaling in the Nervous System—A Review and Perspective:

  2014cites this paper